Related Experiment Videos
Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study
Leila R Zelnick1, Ronit Katz1, Bessie A Young2
1Kidney Research Institute, University of Washington, Seattle, WA; Division of Nephrology, University of Washington, Seattle, WA.
Insights
Increased left ventricular mass (LVM) is linked to kidney function decline in African Americans. Early intervention targeting LVM may help prevent kidney disease progression in this population.
Area of Science:
- Cardiology
- Nephrology
- Epidemiology
Background:
- Cardiac structural abnormalities are prevalent in African Americans and linked to poor outcomes.
- The relationship between subclinical heart failure indicators from echocardiography and kidney function decline in this demographic is not well understood.
- Identifying novel risk factors for kidney disease is crucial for this high-risk population.
Purpose of the Study:
- To investigate the association between echocardiography-derived cardiac measures and kidney function decline in African Americans.
- To determine if subclinical heart failure markers predict kidney disease progression in this population.
Main Methods:
- A prospective cohort study of 2,418 participants from the Jackson Heart Study.
- Baseline echocardiograms assessed left ventricular mass (LVM), ejection fraction (LVEF), and pulmonary artery systolic pressure (PASP).
- Longitudinal estimated glomerular filtration rate (eGFR) decline and progression to end-stage renal disease (ESRD) were primary outcomes, analyzed using logistic regression models.
Main Results:
- Greater LVM was significantly associated with an increased odds of >30% eGFR decline or ESRD (adjusted OR, 1.38).
- No significant associations were found between LVEF or PASP and kidney function decline or ESRD.
- The study included 2,418 participants with a mean age of 52.2 years, and primary/secondary outcomes occurred in 6.1% and 7.1% of participants, respectively.
Conclusions:
- Elevated left ventricular mass is a significant predictor of kidney function decline and progression to ESRD in African Americans.
- Targeting and reducing LVM may be a potential strategy to mitigate kidney disease burden in this high-risk group.
- Further research is needed to explore the clinical implications of these findings for kidney disease prevention.
Background:
Cardiac structural abnormalities, common in African Americans, are associated with adverse clinical outcomes. Associations between echocardiography-measured subclinical heart failure and kidney function decline are unknown and may identify novel risk factors for kidney disease in this population.
Study Design:
Prospective cohort study.
Setting & Participants:
2,418 Jackson Heart Study participants with baseline echocardiograms and longitudinal measures of estimated glomerular filtration rate (eGFR) calculated from the CKD-EPI creatinine equation. 2,219 participants had baseline eGFRs≥60mL/min/1.73m2.
Predictors:
Left ventricular mass (LVM) and ejection fraction (LVEF) and pulmonary artery systolic pressure (PASP) quantified from baseline echocardiograms.
Outcomes:
Primary outcome was >30% eGFR decline or progression to end-stage renal disease (ESRD; need for dialysis therapy) over a mean of 8 years. Secondary outcome, eGFR<60mL/min/1.73m2 or progression to ESRD and eGFR decline >1mL/min/1.73m2 per year among those with baseline eGFRs≥60mL/min/1.73m2.
Measurements:
Logistic regression models, adjusted for demographics, physical characteristics, comorbid conditions, and medication use.
Results:
Mean age was 52.2±11.9 (SD) years, 37% of participants were men; mean baseline eGFR was 87.3±17.3mL/min/1.73m2. The primary and secondary outcomes occurred in 148 (6.1%) and 162 (7.1%) participants, respectively. In unadjusted models, every 25-g greater LVM was significantly associated with greater odds of eGFR decline > 30% or ESRD (OR, 1.38; 95% CI, 1.26-1.51) and incident eGFR<60mL/min/1.73m2 or ESRD (OR, 1.30; 95% CI, 1.20-1.42); only the former remained statistically significant after adjustment. There was no association of LVEF or PASP with either eGFR decline > 30% or ESRD (LVEF: adjusted OR, 0.95 [95% CI, 0.84-1.07]; PASP: adjusted OR, 0.98 [95% CI, 0.87-1.11]) or incident eGFR<60mL/min/1.73m2 or ESRD (LVEF: adjusted OR, 0.98 [95% CI, 0.86-1.11]; PASP: adjusted OR, 1.05 [95% CI, 0.94-1.18]) in multivariable models.
Limitations:
No midstudy creatinine measurement at examination 2.
Conclusions:
Greater LVM was significantly associated with eGFR decline > 30% or ESRD among African Americans in a community-based cohort. Treating and reversing elevated LVM may reduce the burden and progression of kidney disease in this high-risk population.
Related Concept Videos
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
01:28Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...